Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

CANbridge Life Sciences

CANbridge Life Sciences
2012 FOUNDED
PRIVATE STATUS
Series B LATEST DEAL TYPE
$25M LATEST DEAL AMOUNT
7 INVESTORS
Description

Developer of specialty healthcare products designed to treat critical medical conditions. The company's specialty healthcare products prevent and treat high-profile oral mucositis, breast cancer, genetic diseases, and other chronic diseases, enabling patients to access improved treatment.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Primary Office
  • Suite 301, 3F, Timeloit
  • Number 17 RongChuang Road, Chaoyang District
  • Beijing, 100102
  • China

+86 010 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore CANbridge Life Sciences’s full profile, request a free trial.

CANbridge Life Sciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 21-Feb-2017 $25M 000.00 0000 Completed Generating Revenue
3. Early Stage VC (Series A2) 01-Nov-2015 000 000.00 0000 Completed Generating Revenue
2. Early Stage VC (Series A1) 01-Dec-2014 $5M $6.14M 0000 Completed Generating Revenue
1. Angel (individual) 06-Jun-2013 $1.14M $1.14M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

CANbridge Life Sciences Competitors (42)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abbisko Therapeutics Venture Capital-Backed Shanghai, China 00000 00000000000 00000
0000 0000000000 Venture Capital-Backed Beijing, China 0000 0000000000 0 0000
000000000 00000000 Formerly VC-backed South San Francisco, CA 00 00000 00000000 00000
0000 00000000000 Venture Capital-Backed Shanghai, China 00000 00000000000 00000
0000000 Formerly PE-Backed Beijing, China 0000 00.000 000000000 00.000
To view this company’s complete list of competitors, request access »

CANbridge Life Sciences Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
AppTec Laboratory Services Corporation Minority 000 0000 000000 0
Biossom Investment Management Other Minority 000 0000 000000 0
Lapam Capital Other Minority 000 0000 000000 0
Yanyuan Capital Other Minority 000 0000 000000 0
YuanMing Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

CANbridge Life Sciences Executive Team (11)

Name Title Board
Seat
Contact
Info
James Xue Ph.D Founder, Chief Executive Officer and Chairman
Glenn Hassan Chief Financial Officer & Chief Business Officer
Paul Wagner Ph.D Chief Business Officer & Senior Vice President
Mark Goldberg MD Advisor
Gerald Cox MD Chief Development Strategist and Interim Chief Medical Officer

5 Former Executives

You’re viewing 5 of 11 executives. Get the full list »

CANbridge Life Sciences Board Members (2)

Name Representing Role Since Contact
Info
James Xue Ph.D CANbridge Life Sciences Founder, Chief Executive Officer and Chairman 000 0000
William Hu Qiming Venture Partners Board Member 000 0000